0.21 USD
▲-0.01+6.11%
盘后 0.21 +3.94%
2026-08-03
市值
$5.35M
市盈率
—
EPS
-0.97
股息率
—
52 周区间
0.16 – 1.89
成交量
235.32K
Beta
0.64
目标价
8.00
52W 低 0.1652W 高 1.89
价格走势
公司简介
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the treatment of disc/spine disease and metabolic disorders. Its products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient’s bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to ...